Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Schlicker

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Pharmacology & Therapeutics|December 1, 2016
Human presynaptic receptorsEberhard Schlicker, Thomas Feuerstein
Handbook of Experimental Pharmacology|October 28, 2016
Role of the Histamine H<sub>3</sub> Receptor in the Central Nervous SystemEberhard Schlicker, Markus Kathmann
Neuropharmacology|July 28, 2015
A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptorsDoris Petri, Eberhard Schlicker
Frontiers in Cardiovascular Medicine|June 28, 2021
β<sub>1</sub>-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart FailureThomas J Feuerstein, Eberhard Schlicker
British Journal of Pharmacology|May 2, 2003
Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged miceAgnes Redmer, Markus Kathmann, Eberhard Schlicker
Antioxidants (Basel, Switzerland)|April 29, 2025
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?Piotr Ryszkiewicz, Eberhard Schlicker, Barbara Malinowska
British Journal of Pharmacology|May 26, 2004
Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed ratsGrzegorz Godlewski, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports : PR|March 17, 2025
Polypharmacology: new drugs in 2023-2024Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2018
N-Ethylmaleimide differentiates between the M<sub>2</sub>- and M<sub>4</sub>-autoreceptor-mediated inhibition of acetylcholine release in the mouse brainJustine Etscheid, Klaus Mohr, Eberhard Schlicker
Cells|May 14, 2022
Cross-Talk between CB<sub>1</sub>, AT<sub>1</sub>, AT<sub>2</sub> and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive ControlsKrzysztof Mińczuk, Eberhard Schlicker, Barbara Malinowska
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Pharmacology & Therapeutics|December 1, 2016
Human presynaptic receptorsEberhard Schlicker, Thomas Feuerstein
Handbook of Experimental Pharmacology|October 28, 2016
Role of the Histamine H<sub>3</sub> Receptor in the Central Nervous SystemEberhard Schlicker, Markus Kathmann
Neuropharmacology|July 28, 2015
A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptorsDoris Petri, Eberhard Schlicker
Frontiers in Cardiovascular Medicine|June 28, 2021
β<sub>1</sub>-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart FailureThomas J Feuerstein, Eberhard Schlicker
British Journal of Pharmacology|May 2, 2003
Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged miceAgnes Redmer, Markus Kathmann, Eberhard Schlicker
Antioxidants (Basel, Switzerland)|April 29, 2025
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?Piotr Ryszkiewicz, Eberhard Schlicker, Barbara Malinowska
British Journal of Pharmacology|May 26, 2004
Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed ratsGrzegorz Godlewski, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports : PR|March 17, 2025
Polypharmacology: new drugs in 2023-2024Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2018
N-Ethylmaleimide differentiates between the M<sub>2</sub>- and M<sub>4</sub>-autoreceptor-mediated inhibition of acetylcholine release in the mouse brainJustine Etscheid, Klaus Mohr, Eberhard Schlicker
Cells|May 14, 2022
Cross-Talk between CB<sub>1</sub>, AT<sub>1</sub>, AT<sub>2</sub> and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive ControlsKrzysztof Mińczuk, Eberhard Schlicker, Barbara Malinowska
Pageof 7